gMendel

Private

CopenhagenHealthcare & Life Scienceshttps://g-mendel.com/

Last Round

Seed

Apr 15, 2026

Total Funding Raised

$4.38M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

gMendel is a Danish medical technology company that provides an AI-powered software platform for affordable and scalable mass screening of genetic disorders.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical AI, Precision Medicine, Healthcare Analytics

Business Model

B2B

Customer Profile

Usage-Based SaaS, Services & Consulting

AI Layer

Application

Keywords

genetic testinggenomic analysisrare disease diagnosisclinical decision supportprecision medicineAI diagnosticsin vitro diagnosticsIVDnewborn screeninggenomic softwarevariant callingbioinformatics automationhealth-techmedtechdiagnostic SaaS

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

gMendel Comps

Public and private peers based on sector, stage, and business model.

gMendel comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

gMendel Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Seed	Apr 15, 2026
Grant	Nov 1, 2023
Grant	Mar 2, 2023

View all Funding Rounds

Key People

Founding team and executive leadership

Chris Kyriakidis

CEO & Co-Founder

Founding Team

gMendel Investors

Notable investors and investment history

gMendel investors
Investor	Rounds
Innovation Fund Denmark	Grant
Nordic Asian Venture Alliance	Seed
Eurostars SME programme	Grant
Danish Agency for Higher Education and Science	Grant
CVX Ventures	Seed, Angel
Metavallon	Seed
EU Eureka Innowwide	Grant

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Apr 15, 2026
$1.4M raised in Seed funding.

View all signals

gMendel Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

gMendel Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about gMendel's valuation, stock price, and market status.

Firmographic Details

HeadquartersCopenhagen

Employee Range8

Year Founded2020

Last FundingApr 15, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.